Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Zopiclone
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Purdue Pharmaceuticals L.P
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 22, 2015
Lead Product(s) : Zopiclone
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Purdue Pharmaceuticals L.P
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 09, 2011
Lead Product(s) : Zopiclone
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : SINTEF Health Research | Norwegian University of Science and Technology | Norwegian Institute of Public Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Driving Simulator Performance After Intake of Zopiclone Sleeping Pills
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 09, 2010
Lead Product(s) : Zopiclone
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : SINTEF Health Research | Norwegian University of Science and Technology | Norwegian Institute of Public Health
Deal Size : Inapplicable
Deal Type : Inapplicable